Stocks › BHC
Bausch Health Companies Inc.
BHC·NYSE·
Canada·USD
Canada·USD$6.15
+0.13 (+2.16%)
Close · Oct 7, 2026 · Close Prices from Tiingo.com
BHC
Bausch Health Companies Inc. · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
BHCS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of BHC by members of U.S. Congress · 3 on record
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
 Susie LeeHouse · D · NV |
BHCBausch Health Companies Inc. · Stock |
Sale $1,001 - $15,000 |
Oct 7, 2020 | Aug 27, 2020 | Filing ↗ |
| Susie LeeHouse · D · NV |
BHCBausch Health Companies Inc. · Stock |
Purchase $1,001 - $15,000 |
Apr 28, 2020 | Feb 24, 2020 | Filing ↗ |
| Susie LeeHouse · D · NV |
BHCBausch Health Companies Inc. · Stock |
Purchase $1,001 - $15,000 |
Feb 25, 2020 | Jan 6, 2020 | Filing ↗ |
Whale Activity
Position changes in BHC reported for 2026-06-30 by 11 tracked institutional filers
- Increased7
- New0
- Held1
- Decreased2
- Closed0
- No prior filing1
| Filer | Shares | Value | Change |
|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 7.5M | $36.8M | increased |
| D. E. Shaw & Co., Inc. | 2.7M | $13.3M | increased |
| Point72 Asset Management, L.P. | 2.2M | $11.0M | increased |
| TWO SIGMA INVESTMENTS, LP | 2.1M | $10.5M | increased |
| RENAISSANCE TECHNOLOGIES LLC | 1.3M | $6.5M | decreased |
| CITADEL ADVISORS LLC | 1.1M | $5.4M | increased |
| MILLENNIUM MANAGEMENT LLC | 1.1M | $5.4M | increased |
| Bridgewater Associates, LP | 866.3K | $4.3M | increased |
| BlackRock, Inc. | 134.5K | $663K | decreased |
| Bruce & Co., Inc. | 124.0K | $611K | held |
| Eschler Asset Management LLP | 37.5K | $185K | — |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by BHC insiders, by quarter · Form 4
Recent Insider Transactions
590 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Lenar Aimee J.President, US Pharma | Sale | −36.8K | $7.03 | $259K | Aug 19, 2026 | Form 4 ↗ |
| WECHSLER AMY BDirector | Grant / award | +45.9K | $0.00 | $0 | May 22, 2026 | Form 4 ↗ |
| ROBERTS EIRYDirector | Grant / award | +45.9K | $0.00 | $0 | May 22, 2026 | Form 4 ↗ |
| POWER ROBERT NDirector | Grant / award | +45.9K | $0.00 | $0 | May 22, 2026 | Form 4 ↗ |
| Paulson JohnDirector | Grant / award | +45.9K | $0.00 | $0 | May 22, 2026 | Form 4 ↗ |
| LEUNG SANDRADirector | Grant / award | +45.9K | $0.00 | $0 | May 22, 2026 | Form 4 ↗ |
| Lee Frank D.Director | Grant / award | +45.9K | $0.00 | $0 | May 22, 2026 | Form 4 ↗ |
| KAVANAGH SARAH BDirector | Grant / award | +45.9K | $0.00 | $0 | May 22, 2026 | Form 4 ↗ |
| GOETTLER MICHAELDirector | Grant / award | +45.9K | $0.00 | $0 | May 22, 2026 | Form 4 ↗ |
| Garcia Christian ADirector | Grant / award | +45.9K | $0.00 | $0 | May 22, 2026 | Form 4 ↗ |
| Lee Frank D.Director | Sale | −24.5K | $5.43 | $133K | May 19, 2026 | Form 4 ↗ |
| LEUNG SANDRADirector | Grant / award | +5,946 | $5.40 | $32K | Mar 31, 2026 | Form 4 ↗ |
| Paulson JohnDirector | Grant / award | +11.6K | $5.40 | $62K | Mar 31, 2026 | Form 4 ↗ |
| WECHSLER AMY BDirector | Grant / award | +1,273 | $5.40 | $7K | Mar 31, 2026 | Form 4 ↗ |
| Carson SeanaEVP, General Counsel | Sale | −4,420 | $5.77 | $26K | Mar 3, 2026 | Form 4 ↗ |
| Carson SeanaEVP, General Counsel | Other | −137.9K | $5.95 | $821K | Mar 2, 2026 | Form 4 ↗ |
| Carson SeanaEVP, General Counsel | Tax withholding | −17.0K | $5.95 | $101K | Mar 2, 2026 | Form 4 ↗ |
| Carson SeanaEVP, General Counsel | Sale | −6,856 | $5.78 | $40K | Mar 2, 2026 | Form 4 ↗ |
| APPIO THOMASChief Executive Officer · Director | Other | −1.1M | $5.95 | $6.8M | Mar 2, 2026 | Form 4 ↗ |
| APPIO THOMASChief Executive Officer · Director | Tax withholding | −83.7K | $5.95 | $498K | Mar 2, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding BHC · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND VANGUARD STAR FUNDS | 3.8M | $25.9M | 0.00% | Jul 31, 2026 |
| VANGUARD DEVELOPED MARKETS INDEX FUND VANGUARD TAX-MANAGED FUNDS | 2.5M | $12.2M | 0.00% | Jun 30, 2026 |
| Schwab Fundamental International Equity ETF SCHWAB STRATEGIC TRUST | 1.4M | $7.6M | 0.03% | May 31, 2026 |
| VANGUARD FTSE ALL-WORLD EX-US SMALL-CAP INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 986.1K | $6.8M | 0.05% | Jul 31, 2026 |
| The Canadian Small Company Series DFA INVESTMENT TRUST CO | 815.0K | $5.6M | 0.28% | Jul 31, 2026 |
| Nuveen Quant International Small Cap Equity Fund TIAA-CREF Funds | 850.6K | $4.9M | 0.32% | Apr 30, 2026 |
| INTERNATIONAL CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 594.5K | $4.1M | 0.01% | Jul 31, 2026 |
| Schwab International Small-Cap Equity ETF SCHWAB STRATEGIC TRUST | 542.7K | $2.9M | 0.05% | May 31, 2026 |
| iShares Core MSCI Total International Stock ETF iShares Trust | 377.5K | $2.6M | 0.00% | Jul 31, 2026 |
| iShares Core MSCI International Developed Markets ETF iShares Trust | 358.3K | $2.5M | 0.01% | Jul 31, 2026 |
Mutual funds and ETFs whose N-PORT filings list BHC's shares (CUSIP 071734107), each fund at its latest report since Mar 8, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
No 13D/13G beneficial-ownership filings on record.
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming bausch health companies as client
- BAUSCH HEALTH COMPANIESBAUSCH HEALTH COMPANIES · 2026 Q1 · HCR$330K
Filing ↗ - BAUSCH HEALTH COMPANIESBAUSCH HEALTH COMPANIES · 2025 Q4 · HCR$160K
Filing ↗ - BAUSCH HEALTH COMPANIESBAUSCH HEALTH COMPANIES · 2025 Q3 · HCR$160K
Filing ↗ - BAUSCH HEALTH COMPANIESBAUSCH HEALTH COMPANIES · 2025 Q2 · HCR$160K
Filing ↗ - BAUSCH HEALTH COMPANIESBAUSCH HEALTH COMPANIES · 2025 Q1 · HCR$280K
Filing ↗
Government Contracts
Federal awards to Bausch Health Companies Inc. · USAspending
No federal contract awards found for Bausch Health Companies Inc..
U.S. Patents
Recent USPTO applications naming Bausch Health Companies Inc.
No USPTO patent applications found for Bausch Health Companies Inc..
Annual Financials
From BHC's 10-K filings · XBRL
No annual XBRL figures on record for BHC. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
No stock splits in BHC's price history.
About Bausch Health Companies Inc.
From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersQUEBEC, Quebec, Canada
IncorporatedNJ
SEC CIK0000885590 ↗
Former namesValeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL